[1] 姚金晶,陈宜涛.Th1/Th2平衡调节与疾病发生的研究进展[J].现代生物医学进展 2009,9(13):2597-2599. [2] 彭广华.从Th1_Th2漂移探讨千佛菌对环磷酰胺模型小鼠的免疫调节作用[J].陕西中医学院学报2007,29(3):3-36. [3] MARK L, CEZMI A, RODOLF V.Immunological mechanisms of allergen-specific immunotherapy[J].Nature 2006, 6: 761-771. [4] STEPHAN B, SHELIA E.Gastrointestinal Food Allergy: New Insights Into Pathophysiology and Clinical Perspectives[J]. Gastroenterology 2005,128(4):1089-1113. [5] Zhong-xiao W, Feng Z, Qian G, et al. Effect of orally administered bovine colostrum on cytokine production in vivo and in vitro in immunosuppressed mice[J].International Dairy Journal 2010,20:522-527. [6] Artym J, Zimecki M, Kruzel ML. Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is Correlated with renewal of T cell compartment[J]. Immunobiology 2003,207:197-205. [7] Artym J, Zimecki M, Paprocka M, et al. Orally administered lactoferrin restores humoral immune response in immunocompromised mice[J]. Immunology Letters 2003,89:9-15. [8] Matar P, Rozados VR, Silvia I, et al. Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma Model[J]. Cancer Immunol Immunother 2002,50:588-596. [9] 李斐,黎海芪.金银花水提物对卵清蛋白致敏小鼠的抗过敏作用研究[J].重庆医科大学学报 2004,29(03):288-291. [10]白枫,黎海芪.黄褐毛忍冬总皂苷对卵清蛋白致敏小鼠的免疫调节作用[J].重庆医科大学学报 2010,35(04):504-511. [11]Astrid GS, Maarten JF, Huub FJ, et al. IgE and mast cell responses on intestinal allergen exposure: A murine model to study the onset Of food allergy[J]. J ALLERGY CLIN IMMUNOL 1997,98(01):94-99. [12]Eric B, Richard T, Dan H, et al. Mast cells are required for experimental oral allergen-induced diarrhea[J]. The Journal of Clinical Investigation 2003,112(11):1666-1677. [13]Mubeccel A, Johan V, Alison T, et al, Immune Response in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells[J].The Journal of Experimental Medicine 2004,199(06):1567-1575. [14]MOSMANN TR, CHERWINSKI H, BOND MW, Two types of murine helper T cell clone I definition according to profiles of lymohokine activities and secreted proteins [J].J Immunol 1986,136:2348-2357. [15]Pablo M, Viviana R, Silvia I, et al. Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma mode[J]. Cancer Immunol Immunother 2002,10(50):588-596. [16]Francoise C, Steven D.H, Robert L.C, et al. T Regulatory Cells 1 Inhibit a Th2-Specific Response In Vivo[J]. Journal of Immunology 2000,165:4848-4853. [17]Shinichiro K, Hidekazu T, Masazumi T, et al, IL-10 controls Th2-type cytokine production and eosinophil infiltration in a mouse model of allergic airway inflammation[J]. Immunobiology 2010,12(9):1-10. [18]Alison T, Johan V, Kurt B,et al. Mechanisms of immune suppression by inteleukin-10 and transforming growth factor-β:the role of T regulatory cells[J].Immunology 2006,117:433-442. [19]Brode S, Cooke A. Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide[J].Critical Reviews in Immunology 2008,28:109-126. [20]Matar P, Rozados VR, Gonzalez AD, et al. Mechanism of antimetastatic immunopotentiation by low-dose cyclophosphamide[J]. Eur J Cancer 2000,36:1060. [21]Wendy TW, Masato M, Akio M, et al. The biology of IL-12:coordinating innate and adaptive immune responses[J]. Cytokine & Growth Factor Reviews 2003,14:361-368. [22]Sean D, Mercedes R. The two faces of IL-6 on Th1/Th2 differentiation[J].Molecular Immunology 2002,39:531-536. [23]Oliver D, Mercedes R. The effects of IL-6 on CD4 T cell reponses[J]. Clinical Immunology 2009,130:27-33. |